Edwards Lifesciences Corporation
EWNYSEHealthcareMedical Devices

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Company Information

CEOBernard Zovighian
Founded1958
IPO DateMarch 27, 2000
Employees15,800
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone949 250 2500
Address
One Edwards Way Irvine, California 92614 United States

Corporate Identifiers

CIK0001099800
CUSIP28176E108
ISINUS28176E1082
EIN36-4316614
SIC3842

Leadership Team & Key Executives

Bernard J. Zovighian
Chief Executive Officer and Director
Scott B. Ullem
Corporate Vice President and Chief Financial Officer
Donald E. Bobo Jr.
Corporate Vice President of Strategy and Corporate Development
Jean-Luc Lemercier
Corporate Vice President of Japan, Asia Pacific and Greater China
Daveen Chopra
Corporate Vice President of Transcatheter Mitral and Tricuspid Therapies
Andrew M. Dahl
Principal Accounting Officer, Senior Vice President and Corporate Controller
Dr. Todd J. Brinton FACC, M.D.
Corporate Vice President of Advanced Innovation and Technology and Chief Scientific Officer
Mark Wilterding
Vice President of Investor Relations
Mark D. Peterson
Corporate Vice President and General Counsel
Dirksen J. Lehman
Corporate Vice President of Public Affairs